Properties
                                        
                            Description
                            EBI-1051 prevents the phosphorylation and activation of ERK leading to reduced cell proliferation and induced apoptosis in cancerous cells.
                         
                                                                            
                                                            
                            Molecular Formula
                            C18H15F2IN2O5
                         
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
                                                            
                                                                                                                                                                                            
                            Identity
                            Confirmed by NMR/HPLC/MS.
                         
                                                                                                                                                            
                            Applications
                            EBI-1051 can be used to investigate its activity as a kinase inhibitor in cancer and other diseases where kinase signaling is dysregulated.